ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.33
-0.15 (-1.11%)
At close: Aug 6, 2026, 4:00 PM EDT
13.75
+0.42 (3.15%)
After-hours: Aug 6, 2026, 6:45 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $119.54 million as of August 6, 2026. Its market cap has increased by 445.80% in one year.
Market Cap
119.54M
Enterprise Value
59.01M
1-Year Change
445.80%
Ranking
Category
Stock Price
$13.33
ChartMarket Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $119.54M, an increase of 447.80%. That is a compound annual growth rate of 12.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 119.54M | 713.72% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 129.50M |
| Spruce Biosciences | 127.76M |
| Tiziana Life Sciences | 125.98M |
| enGene Therapeutics | 120.58M |
| Seer, Inc. | 120.41M |
| Genelux | 119.90M |
| Vivani Medical | 117.28M |
| Anixa Biosciences | 116.70M |